(Q38337047)

2 September 2017

title

Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses (English)

1 reference

2 September 2017

1 reference

1 reference

Sophie Girard

1

1 reference

2 September 2017

Erik Vossman

2

1 reference

2 September 2017

David E Misek

3

1 reference

2 September 2017

Philippe Podevin

4

1 reference

2 September 2017

Samir Hanash

5

1 reference

2 September 2017

Christian Bréchot

6

1 reference

2 September 2017

Laura Beretta

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

2 September 2017

1 reference

2 September 2017

volume

40

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

708-718

1 reference

Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis

2 September 2017

cites work

1 reference

Liver fibrosis and altered matrix synthesis

21 January 2018

1 reference

Regulation of liver inflammatory injury by signal transducer and activator of transcription-6.

21 January 2018

1 reference

Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression

21 January 2018

1 reference

Epidemiology of hepatitis C

21 January 2018

1 reference

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

7 January 2021

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

1 reference

7 January 2021

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations

1 reference

7 January 2021

Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner

1 reference

7 January 2021

An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis

1 reference

7 January 2021

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

1 reference

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

7 January 2021

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

1 reference

7 January 2021

Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity

1 reference

7 January 2021

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

1 reference

7 January 2021

Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication

1 reference

7 January 2021

MATCH: A tool for searching transcription factor binding sites in DNA sequences

1 reference

7 January 2021

The TRANSFAC system on gene expression regulation.

1 reference

7 January 2021

Gibbs Recursive Sampler: finding transcription factor binding sites

1 reference

7 January 2021

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

1 reference

7 January 2021

Neurotensin and hepatocellular carcinoma

1 reference

7 January 2021

Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma

1 reference

7 January 2021

Overexpression of aldose reductase in liver cancers may contribute to drug resistance

1 reference

7 January 2021

Overexpression of osteopontin in hepatocellular carcinoma

1 reference

7 January 2021

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization

1 reference

7 January 2021

Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma

1 reference

7 January 2021

Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma

1 reference

7 January 2021

In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C.

1 reference

7 January 2021

Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury

1 reference

7 January 2021

The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

1 reference

7 January 2021

Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C

1 reference

7 January 2021

Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis

1 reference

7 January 2021

Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation

1 reference

7 January 2021

Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice

1 reference

7 January 2021

CD47 ligation selectively downregulates human interleukin 12 production

1 reference

7 January 2021

Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice

1 reference

7 January 2021

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

1 reference

7 January 2021

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

1 reference

7 January 2021

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

1 reference

7 January 2021

Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus

1 reference

7 January 2021

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins

1 reference

7 January 2021

Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20371

1 reference

2 September 2017

1 reference